A comprehensive analysis of a database and immunohistochemistry of tumor tissues from a cohort of 290 ICCA patients revealed that CTLA-4+ TILs and PDL1+ TILs independently predict tumor recurrence and OS in iCCA patients after surgical tumor removal [56]. This evidence concerns the gene CTLA4 and neoplasm.